comparemela.com

Page 4 - Laura Gault News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Reviewing Zuranolone Pill to Treat Postpartum Depression (VIDEO)

The FDA is reviewing Zuranolone, which is a 14-day oral treatment for adults with postpartum depression or major depressive disorder.

Priya singhalLaura gaultCenters for diseaseDrug administrationSage therapeuticsDisease controlPostpartum depressionMajor depressive disorderOmen 039s healthHealth newsBs newsFood and drug administration

1st pill to treat postpartum depression moves to FDA for review

Zuranolone would be the first pill made to help women struggling with PPD.

United statesLaura gaultCenters for diseaseSage therapeutics incNational institutes of healthDrug administrationBiogen incJournal of the american medical association psychiatrySage therapeuticsDisease controlNational institutesAmerican medical association

First pill to treat postpartum depression could be available this year

The Food and Drug Administration is expected to reveal whether it has approved the first pill to treat postpartum depression later this year.

Priya singhalLaura gaultCenters for diseaseDrug administrationSage therapeuticsDisease control

Cambridge company s postpartum depression pill may hit market this year

A new drug designed to help with postpartum depression could be approved later this year. It would be the first pill of its kind.

United statesUnited kingdomPriya singhalLindsay clancyLaura gaultManuel balce ceneta associatedDrug administrationBoston globeCambridge based sage therapeuticManuel balceSage therapeuticsBoston childrenChief medical officer laura gaultBiogen executive vice president priya singhal

First pill to treat postpartum depression could be available this year

The Food and Drug Administration is expected to reveal whether it has approved the first pill to treat postpartum depression later this year.

Priya singhalLaura gaultCenters for diseaseDrug administrationSage therapeuticsDisease control

vimarsana © 2020. All Rights Reserved.